Neutropenia during the First Cycle of Induction Chemotherapy Is Prognostic for Poor Survival in Locoregionally Advanced Nasopharyngeal Carcinoma: A Real-World Study in an Endemic Area

被引:7
作者
Xu, Cheng [1 ]
Yang, Shi-Ping [2 ]
Zhang, Yuan [1 ]
Tang, Ling-Long [1 ]
Zhou, Guan-Qun [1 ]
Liu, Xu [1 ]
Mao, Yan-Ping [1 ]
Duo, Rui [1 ]
Li, Wen-Fei [1 ]
Chen, Lei [1 ]
Lin, Ai-Hua [3 ]
Sun, Ying [1 ]
Ma, Jun [1 ]
机构
[1] Sun Yat Sen Univ, Dept Radiat Oncol, Canc Ctr, State Key Lab Oncol South China,Collaborat Innova, 651 Dongfeng Rd East, Guangzhou 510060, Guangdong, Peoples R China
[2] Hainan Prov Peoples Hosp, Dept Radiol, Haikou, Hainan, Peoples R China
[3] Sun Yat Sen Univ, Sch Publ Hlth, Dept Med Stat & Epidemiol, Guangzhou, Guangdong, Peoples R China
来源
CANCER RESEARCH AND TREATMENT | 2018年 / 50卷 / 03期
基金
中国国家自然科学基金;
关键词
Induction chemotherapy; Nasopharyngeal carcinoma; Neutropenia; Lymphocyte; Prognosis; Survival; CELL LUNG-CANCER; PLUS CONCURRENT CHEMORADIOTHERAPY; PLATELET-LYMPHOCYTE RATIO; FEBRILE NEUTROPENIA; BIOMARKER; TRIAL; LYMPHOPENIA; NOMOGRAM; RISK;
D O I
10.4143/crt.2017.255
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose The purpose of this study was to investigate the effect of neutropenia during the first cycle of induction chemotherapy (IC-1) on survival in locoregionally advanced nasopharyngeal carcinoma (LANPC). Materials and Methods Eligible patients (n=545) with LANPC receiving IC+concurrent chemoradiotherapy were included. Based on nadir neutrophil after IC-1, all patients were categorized into three groups: no/grade 1-2/grade 3-4 neutropenia. Five-year overall survival (OS) and disease-free survival (DFS) were compared between groups and subgroups stratified by IC regimen. We also explored the occurrence of IC-1-induced myelosuppression events and the minimal value of post-treatment neutrophil-to-lymphocyte ratio (post-NLRmin). Univariate/multivariate analyses were performed to investigate the effect of IC-1-induced neutropenia, timing of neutropenia, number of myelosuppression events, and high post-NLRmin on OS/DFS. Results Grade 1-2/grade 3-4 neutropenia were associated with poorer OS/DFS than no neutropenia (all p < 0.05); OS/DFS were not significantly different between patients experiencing grade 1-2 vs. 3-4 neutropenia. Neutropenia had no significant effect on OS/DFS in patients receiving docetaxel-cisplatin-5-fluorouracil (TPF). Grade 1-2 (grade 3-4) neutropenia negatively influenced OS/DFS in patients receiving cisplatin-5-fluorouracil (PF) (PF and docetaxel-cisplatin [TP]; all p < 0.05). Neutropenia, two/three myelosuppression events, and high post-NLRmin (>= 1.33) was most frequent on days 5-10, second and third week of IC-1, respectively. After adjustment for covariates, IC-1-induced neutropenia, two/three myelosuppression events, and post-NLRmin >= 1.33 were validated as negative predictors of OS/DFS (all p < 0.05); timing of neutropenia had no significant effect. Conclusion Occurrence of neutropenia, number of myelosuppression events, and high post-NLRmin during PF/TP IC-1 have prognostic value for poor survival in LANPC.
引用
收藏
页码:777 / 790
页数:14
相关论文
共 30 条
[1]   Elevated neutrophil to lymphocyte ratio predicts poor prognosis in nasopharyngeal carcinoma [J].
An, Xin ;
Ding, Pei-Rong ;
Wang, Feng-Hua ;
Jiang, Wen-Qi ;
Li, Yu-Hong .
TUMOR BIOLOGY, 2011, 32 (02) :317-324
[2]   The value of the pretreatment neutrophil lymphocyte ratio vs. platelet lymphocyte ratio in predicting the long-term survival in colorectal cancer [J].
Azab, Basem ;
Mohammad, Farhan ;
Shah, Neeraj ;
Vonfrolio, Steven ;
Lu, William ;
Kedia, Shiksha ;
Bloom, ScottW. .
CANCER BIOMARKERS, 2014, 14 (05) :303-312
[3]   Early lymphopenia after cytotoxic chemotherapy as a risk factor for febrile neutropenia [J].
Blay, JY ;
Chauvin, F ;
LeCesne, A ;
Anglaret, B ;
Bouhour, D ;
Lasset, C ;
Freyer, G ;
Philip, T ;
Biron, P .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (02) :636-643
[4]   Chemotherapy-related leukopenia as a biomarker predicting survival outcomes in locally advanced cervical cancer [J].
Bogani, Giorgio ;
Sabatucci, Ilaria ;
Maltese, Giuseppa ;
Lecce, Francesca ;
Signorelli, Mauro ;
Martinelli, Fabio ;
Chiappa, Valentina ;
Indini, Alice ;
Maggiore, Umberto Leone Roberti ;
Borghi, Chiara ;
Fuca, Giovanni ;
Ditto, Antonino ;
Raspagliesi, Francesco ;
Lorusso, Domenica .
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2017, 208 :41-45
[5]   Allogeneic and autologous stem-cell transplantation in advanced Ewing tumors -: An update after long-term follow-up from two centers of the European Intergroup Study EICESS [J].
Burdach, S ;
van Kaick, B ;
Laws, HJ ;
Ahrens, S ;
Haase, R ;
Körholz, D ;
Pape, H ;
Dunst, J ;
Kahn, T ;
Willers, R ;
Engel, B ;
Dirksen, U ;
Kramm, C ;
Nürnberger, W ;
Heyll, A ;
Ladenstein, R ;
Gadner, H ;
Jürgens, H ;
Göbel, U .
ANNALS OF ONCOLOGY, 2000, 11 (11) :1451-1462
[6]   Timing of chemotherapy-induced neutropenia predicts prognosis in metastatic colon cancer patients: a retrospective study in mFOLFOX6-treated patients [J].
Chen, Yang ;
Wang, YanRong ;
Shi, Yan ;
Dai, GuangHai .
BMC CANCER, 2017, 17
[7]   Chemotherapy-induced neutropenia - Risks, consequences, and new directions for its management [J].
Crawford, J ;
Dale, DC ;
Lyman, GH .
CANCER, 2004, 100 (02) :228-237
[8]   Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of three randomised trials [J].
Di Maio, M ;
Gridelli, C ;
Gallo, C ;
Shepherd, F ;
Piantedosi, FV ;
Cigolari, S ;
Manzione, L ;
Illiano, A ;
Barbera, S ;
Robbiati, SF ;
Frontini, L ;
Piazza, E ;
Ianniello, GP ;
Veltri, E ;
Castiglione, F ;
Rosetti, F ;
Gebbia, V ;
Seymour, L ;
Chiodini, P ;
Perrone, F .
LANCET ONCOLOGY, 2005, 6 (09) :669-677
[9]   Cancer-related inflammation and treatment effectiveness [J].
Diakos, Connie I. ;
Charles, Kellie A. ;
McMillan, Donald C. ;
Clarke, Stephen J. .
LANCET ONCOLOGY, 2014, 15 (11) :E493-E503
[10]   Baseline neutrophils and derived neutrophil-to-lymphocyte ratio: prognostic relevance in metastatic melanoma patients receiving ipilimumab [J].
Ferrucci, P. F. ;
Ascierto, P. A. ;
Pigozzo, J. ;
Del Vecchio, M. ;
Maio, M. ;
Cappellini, G. C. Antonini ;
Guidoboni, M. ;
Queirolo, P. ;
Savoia, P. ;
Mandala, M. ;
Simeone, E. ;
Valpione, S. ;
Altomonte, M. ;
Spagnolo, F. ;
Cocorocchio, E. ;
Gandini, S. ;
Giannarelli, D. ;
Martinoli, C. .
ANNALS OF ONCOLOGY, 2016, 27 (04) :732-738